Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
01 2월 2025 - 12:04AM
Edgar (US Regulatory)
EXHIBIT
A
SCHEDULE
13D/A
JOINT FILING AGREEMENT TERMINATION
Each
of the undersigned is a party to that certain Joint Filing Agreement, dated as of June 5, 2023 (the “Joint Filing Agreement”).
In accordance with the Joint Filing Agreement, each of the undersigned hereby agrees that the Joint Filing Agreement is terminated, effective
as of December 31, 2024.
IN
WITNESS WHEREOF, the parties have executed this Joint Filing Agreement Termination on January 24, 2025.
D&D
SOURCE OF LIFE HOLDING LTD.
By: |
Era Regenerative Medicine Limited, a BVI company |
|
Its: |
Sole Shareholder |
|
|
|
|
Signed: |
/s/ Qi Meng |
|
By: |
Qi Meng |
|
Its: |
Director |
|
SHUFEN
DENG |
|
|
|
/s/
Shufen Deng |
|
Reeds (QX) (USOTC:REED)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Reeds (QX) (USOTC:REED)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
Reeds Inc (QX) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Reeds Inc (QX) News Articles